TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer

Presently, there are few validated biomarkers that can predict survival or treatment response for non-small cell lung cancer (NSCLC) and most are based on tumor markers. Biomarkers based on germ line DNA variations represent a valuable complementary strategy, which could have translational implicati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Schabath, Matthew B., Giuliano, Anna R., Thompson, Zachary J., Amankwah, Ernest K., Gray, Jhanelle E., Fenstermacher, David A., Jonathan, Kristen A., Beg, Amer A., Haura, Eric B.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2013
Matèries:
Original Manuscript
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3810840/
https://ncbi.nlm.nih.gov/pubmed/23839018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgt244
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars